Category Archive for: "Coverage"
Scrip’s John Davis wrote an article on Amphera:
https://scrip.pharmaintelligence.informa.com/SC124930/Amphera-Gears-Up-To-Evaluate-Dendritic-Cells-For-Pleural-Mesothelioma
Nuala Moran of BioWorld covered Amphera’s press release as well:
http://www.bioworld.com/content/amphera-taking-mesothelioma-dendritic-cell-vaccine
Read more »At BIO Europe Spring 2019 in Vienna, Rob Meijer was interviewed by Mike Ward – Informa on combination therapy of MesoPher and checkpoint inhibitors.
Read more »On January 25, 2018 National and regional newspapers in The Netherlands published an article on the MESOPEC study. Investigator dr. Eva Madsen and a patient are interviewed. MESOPEC is a phase II study with MesoPher in peritoneal mesothelioma.
The article (in Dutch) can be found on: https://www.ad.nl/wetenschap/veelbelovende-behandelmethode-tegen-asbestkanker~a900b9dc/
Read more »Amphera is happy to announce that the results of our phase I/II study with MesoPher in mesothelioma are published in the February 2018 issue of Clinical Cancer Research.
Read more »